Congenital heart disease (CHD) is the most common congenital anomaly in newborn
babies. Cardiac malformations have been produced in multiple experimental animal …

Abstract Purpose of Review Genetic testing has become an important element in the care of
patients with inherited cardiac conditions (ICCs). The purpose of this review is to provide …

Cardiomyopathy frequently has a genetic basis. In adults, mutations in genes encoding
components of the sarcomere, cytoskeleton, or desmosome are frequent genetic causes of …

Genetic testing is now known to provide critical information regarding the treatment,
diagnosis, prognosis, and management of patients with hereditary cardiomyopathies and …

Background: Over 400 genes contribute to the development of congenital heart disease
(CHD). Additionally, multisystemic manifestations accompanying syndromic CHD pose a …

The time has come for the congenital heart disease (CHD) community to identify the ways
our approach to clinical trials will need to change if we want to produce the data necessary …

There has been tremendous growth in the application of genetics to the clinical practice of
pediatric cardiomyopathy. The identification of the genetic basis for cardiomyopathies is …

Extraordinary diagnostic precision and definitive therapies with relatively low morbidity and
mortality characterize the state of the art in the management of congenital heart disease …

Genetic risk assessment for cardiovascular disease is less advanced and less widely
performed to date than it is for cancer. Yet it is no less important. Alert clinicians should" think …

The Expansion of Genetic Testing in Cardiovascular Medicine: Preparing the Cardiology
Community for the Changing Landscape | Current Cardiology Reports Skip to main content …